{"id":"W2970021941","doi":"10.1200/jco.2019.37.15_suppl.11003","title":"Safety and efficacy of tazemetostat, a first-in-class EZH2 inhibitor, in patients (pts) with epithelioid sarcoma (ES) (NCT02601950).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical trial; Phases of clinical research; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009286838,0.0003394501,0.0008933214,0.0002415697,0.000183735,0.0005100048,0.0002499467,0.000550836,0.00221921],"category_scores_gemma":[0.0008841935,0.0001968779,0.0006560076,0.0003872902,0.0003060788,0.0004382835,0.0002136517,0.001169472,0.0004554878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006314721,"about_ca_system_score_gemma":0.0006812853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005594981,"about_ca_topic_score_gemma":0.001755569,"domain_scores_codex":[0.9997799,0.0001028622,0.00002230108,0.00003448875,0.00002985877,0.00003060386],"domain_scores_gemma":[0.9996102,0.00009961679,0.0001338221,0.00002398057,0.00002262034,0.0001097608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6340514,0.0137064,0.07725457,0.001609546,0.002098667,0.0007798203,0.0004521732,0.003371944,0.05080779,0.0002756543,0.006156881,0.2094351],"study_design_scores_gemma":[0.2808848,0.4693538,0.2187594,0.0001522068,0.002238598,0.002001728,0.0002049502,0.003534808,0.009938068,0.000425919,0.01245196,0.0000537694],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942678,0.002147729,0.0001990099,0.0002094624,0.00002518754,0.0004220715,0.001106109,0.00003109701,0.001591452],"genre_scores_gemma":[0.996018,0.0008840688,0.000359203,0.000233802,0.00003501249,0.0002766502,0.001534453,0.000005528118,0.000653258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00221921,"threshold_uncertainty_score":0.007423937,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02045692337153105,"score_gpt":0.338526687649502,"score_spread":0.318069764277971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}